Canaccord Genuity maintained a Buy on Edwards Lifesciences (NYSE: EW) but cut its price target to $109.00 (from $123.00).

This article: 131 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE